ACXP Jul 2024 2.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 10:08AM EDT. Market open.
| Previous Close | 0.7900 |
| Open | 0.7900 |
| Bid | 0.2000 |
| Ask | 1.2500 |
| Strike | 2.00 |
| Expire Date | 2024-07-19 |
| Day's Range | 0.7900 - 0.7900 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 26 |
- GuruFocus.com
Acurx Pharmaceuticals Inc (ACXP) Q1 2024 Earnings Call Transcript Highlights: Key Financial and ...
Explore the financial dynamics and strategic clinical advancements as ACXP progresses with its Phase III trials.
- Thomson Reuters StreetEvents
Q1 2024 Acurx Pharmaceuticals Inc Earnings Call
Q1 2024 Acurx Pharmaceuticals Inc Earnings Call
PR NewswireAcurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today announced the successful outcome of an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA), supporting the advancement of ibezapolstat for the treatment of C. difficile Infection into Phase 3 studies based on the recently completed Phase 2 clinical trial results.
© 2024 Yahoo. All rights reserved.